🔗 Share this article

As the United States proceeds with historic adjustments to its vaccination recommendations, a particular individual has emerged unexpectedly: Dr. Tracy Beth Høeg, a Danish American physician and epidemiologist who initially gained attention by questioning Covid vaccinations throughout the pandemic and has concentrated on possible deaths after Covid immunization in her brief time at the Food and Drug Administration.

Planned Changes to Childhood Immunization Schedule

Health officials were set to announce sweeping changes to the childhood immunization program recently, bringing the US with Denmark’s vaccine program, sources say – a major change that would place the US out of alignment with many the world with little proof for benefit. The announcement has been delayed until the next year.

Instead of Vinay Prasad, Dr. Høeg is listed to speak at the meeting. She was recently named interim head of the FDA’s CDER, the fifth individual to lead the center this calendar year.

A New Direction at the Regulatory Body

This interim role might represent a strengthened alliance between the drug and biologics centers as Dr. Høeg and Prasad consolidate power at the regulatory agency – and it suggests a greater focus upon dismantling previously authorized vaccines at the FDA.

Høeg has often pushed for discontinuing certain pediatric vaccine recommendations in the US to become more in line with Denmark, a society with universal health coverage and a number of inhabitants roughly the population of the state of Wisconsin.

In her initial comments, she has continued to focus on immunizations – traditionally the purview of Dr. Prasad, director of the FDA’s vaccine center – instead of drug regulation.

Questions Over Expertise

Høeg has little discernible experience in drug development, approval processes or leadership, which has been customary for past heads of the CBER. She has served at the FDA as a key advisor to the commissioner and the vaccine center since earlier this year.

“She appears not to have any of the qualifications” for running the drug-regulation department, remarked Jonathan Howard. “She’s never run a scientific study. She is not versed in managing a sizeable institution. She is not an expert in industry regulation.”

Previous heads of CBER would “grasp legal statutes and the research of pharmaceutical innovation”, noted Dr. Janet Woodcock. “Objectively, she lacks the sort of resume that former directors who ran the center have had.”

The drug center has an enormous range of responsibilities at the agency, the former commissioner emphasized.

“The public just pays attention on the innovative therapies, but the off-patent medication office approves numerous generic drugs. There is also a biologic copycat branch, OTC medication office and more, and every single one need to be supervised,” Dr. Woodcock noted. “The thing you don’t keep your eye on, that’s the thing that I always told people is going to come back to haunt you.”

Furthermore, a major administrative aspect to the role, which supervises in excess of 5,000 personnel. “It is a massive management job, if you do it right,” the former official added.

Official Statement and Controversial Programs

In response to concerns about Dr. Høeg's qualifications and whether this assignment represents more teamwork among FDA leaders on vaccines, a press secretary stated that the “concerns rely on incorrect premises”.

“Her resume is consistent with the responsibilities of her job,” the representative explained, pointing to the months Dr. Høeg spent advising the FDA commissioner on “pharmaceutical safety and regulatory science, including computerized risk analysis and immunization monitoring”.

As the temporary head, Høeg assumes responsibility for the agency head's recently launched priority voucher program, a contentious expedited drug-approval program that allegedly concerned her preceding directors. “By what process are these therapies being picked for this fast-track system? Who takes the decisions?” Dr. Howard said. “There is a lot of lack of transparency occurring at the agency right now.”

In general, he said, “the agency looks to be trending towards less stringent regulations of all drugs, with the exception of immunizations.”

Public History on Immunizations

With immunizations, Høeg has a clearer, if troubling, past, Howard said. She authored a study using unverified crowd-sourced reports to estimate the frequency of heart inflammation following Covid immunization. She counseled the Florida chief medical officer Joseph Ladapo, who reportedly have changed statistics to imply COVID-19 vaccines are pose a greater threat than they are.

Among her “desired changes” for the current federal leadership encompassed revising regulations for new vaccines and ending “unnecessary” vaccines, she said after the election on a podcast. At the agency, Høeg has allegedly suggested barring young men from obtaining Covid vaccines.

“She’s an thorough true believer who begins with her preconceived notions and tailors the evidence to fit the data in a highly misleading, fraudulent way,” Dr. Howard said.

Gaining Influence and a “Campaign of Retribution”

Høeg aligned with fellow contrarians, {like|